Poorly differentiated neuroendocrine rectal carcinoma with uncommon immune-histochemical features and clinical presentation with a subcutaneous metastasis, treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimen: an experience of multidisciplinary management in clinical practice.
Negatively differentiated neuroendocrine rectal carcinoma with unusual immune-histochemical features and clinical presentation with subcutaneous metastasis treated with first line intensive triplet chemotherapy plus bevacizumab FIr-B/FOx regimens : an experience of multidisciplinary management in clinical practice.